Literature DB >> 19927942

Anaphylaxis to gadolinium radiocontrast: a case report and review of the literature.

Meagan Shepherd1, Suman Lata, Sandhya Mani, Annette Fiorillo, Prem Kumar.   

Abstract

Gadolinium was first introduced in 1988 for use in magnetic resonance imaging. The safety of gadolinium chelates is well established with lower frequency of adverse reactions than non-ionic iodinated contrast media; however, serious adverse reactions can occur. We report a rare case of anaphylaxis after intravenous administration of gadopentetate dimeglumine (Magnevist), used for magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927942

Source DB:  PubMed          Journal:  J La State Med Soc        ISSN: 0024-6921


  2 in total

1.  Incidental MRI findings of acute gadolinium hypersensitivity.

Authors:  C Amene; L A Yeh-Nayre; C E Dory; J R Crawford
Journal:  Case Rep Neurol       Date:  2012-04-24

2.  Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent.

Authors:  Sabine Franckenberg; Florian Berger; Sarah Schaerli; Garyfalia Ampanozi; Michael Thali
Journal:  Radiol Case Rep       Date:  2017-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.